Maribavir inhibits epstein-barr virus transcription in addition to viral DNA replication
about
RNA-seq detects pharmacological inhibition of Epstein-Barr virus late transcription during spontaneous reactivation.Unexpected patterns of Epstein-Barr virus transcription revealed by a high throughput PCR array for absolute quantification of viral mRNA.Update on new antivirals under development for the treatment of double-stranded DNA virus infectionsKnockout of Epstein-Barr virus BPLF1 retards B-cell transformation and lymphoma formation in humanized mice.Protein kinase inhibitors that inhibit induction of lytic program and replication of Epstein-Barr virus.Epstein-Barr Virus Infection of Mammary Epithelial Cells Promotes Malignant Transformation.Development of drugs for Epstein-Barr virus using high-throughput in silico virtual screeningInhibition of Epstein-Barr virus reactivation by the flavonoid apigenin.Epigenetic modification of the Epstein-Barr virus BZLF1 promoter regulates viral reactivation from latencyGenome-wide analyses of Zta binding to the Epstein-Barr virus genome reveals interactions in both early and late lytic cycles and an epigenetic switch leading to an altered binding profile.Maribavir inhibits Epstein-Barr virus transcription through the EBV protein kinase.Pin1 interacts with the Epstein-Barr virus DNA polymerase catalytic subunit and regulates viral DNA replication.Spectrum of activity and mechanisms of resistance of various nucleoside derivatives against gammaherpesviruses.Inhibition of Epstein-Barr virus reactivation in nasopharyngeal carcinoma cells by dietary sulforaphane.Impact of Epstein-Barr virus donor and recipient serostatus on the incidence of post-transplant lymphoproliferative disorder in kidney transplant recipients.Antiviral Drugs for EBV.The Hsp70 inhibitor 2-phenylethynesulfonamide inhibits replication and carcinogenicity of Epstein-Barr virus by inhibiting the molecular chaperone function of Hsp70
P2860
Q33726183-CBB1AC79-361E-46A4-A49A-C2EEC39460B7Q34703035-2B12FE93-9197-4C25-8B1A-F66325FF3CE6Q36185647-95DB4BC2-427F-473E-B443-2BCADDA0FBD0Q36205880-C162E29C-EBE0-4041-99F7-32AD5C83541DQ36442795-222061B5-45C6-41B9-A9B1-0DED1A1E429CQ37149898-D2482FF1-AA60-467B-8DA7-1CD60453AC41Q37278489-00B91ADC-466D-462D-AB7D-33EC03F138D6Q37566280-557CB778-16D6-4ACF-8EF9-59280BF66C46Q38098179-8F2A06AB-DB80-4C34-95D5-2089A67F80B9Q38321333-213ED562-5D12-4817-B6DF-6ED0EAA6BC3BQ39187112-ACFEB99A-BC88-4A95-BB49-DD172E8E4FACQ39230419-E747F9F4-EF22-439B-BE3C-C021972E5D2AQ41722018-00FB88CE-F95F-48C4-B49E-7C8679A9F341Q42717841-4428C632-EBB1-4635-9899-18E1495587C9Q45360184-62A936DD-0AD7-49E4-BE15-6D76E007B2EEQ55461330-2B0A7915-F4B1-4299-8EDA-A5F3BB5B4C8FQ56476012-082066B2-8282-43FB-BA84-1841DC3F0B9C
P2860
Maribavir inhibits epstein-barr virus transcription in addition to viral DNA replication
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Maribavir inhibits epstein-barr virus transcription in addition to viral DNA replication
@en
Maribavir inhibits epstein-barr virus transcription in addition to viral DNA replication.
@nl
type
label
Maribavir inhibits epstein-barr virus transcription in addition to viral DNA replication
@en
Maribavir inhibits epstein-barr virus transcription in addition to viral DNA replication.
@nl
prefLabel
Maribavir inhibits epstein-barr virus transcription in addition to viral DNA replication
@en
Maribavir inhibits epstein-barr virus transcription in addition to viral DNA replication.
@nl
P2093
P2860
P356
P1433
P1476
Maribavir inhibits epstein-barr virus transcription in addition to viral DNA replication
@en
P2093
Christopher B Whitehurst
Debasmita Roy
Fu-Zhang Wang
Joseph S Pagano
P2860
P304
12108-12117
P356
10.1128/JVI.01575-09
P407
P577
2009-09-16T00:00:00Z